Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_assertion type Assertion NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_head.
- NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_assertion description "[The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_provenance.
- NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_assertion evidence source_evidence_literature NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_provenance.
- NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_assertion SIO_000772 16518403 NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_provenance.
- NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_assertion wasDerivedFrom befree-20140225 NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_provenance.
- NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_assertion wasGeneratedBy ECO_0000203 NP473883.RAYjfeAqaWCl7unENt_AZtVmqV7zdNy9sQJC09ailwfeA130_provenance.